2-chloro-N-(3-phenyl-1,2,4-thiadiazol-5-yl)acetamide, 95.0%, 2.5g

6-chloro-2-(trifluoromethyl)-1,4-dihydroquinazolin-4-one, 95%, 10g

8-Hydroxy-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline-9-carbaldehyde, 95.0%, 5g

4'-Bromo-2'-(trifluoromethyl)acetanilide, 1g

1-ACETYL-6-METHYL-1H-INDAZOLE-3-CARBONITRILE, 95.0%, 100mg

1-(3-Bromophenyl)-2,2-dimethylpropan-1-amine, 95%, 100mg

2,3-Difluoro-5-iodopyridine, 95.0%, 1g

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1), 99%, 25g

1-tetradecylpiperazine, 95.0%, 1g

4-(2,5-Difluorophenyl)thiazol-2-ylamine, 100mg

Palladium(II)-oxid, ROTI®METIC 99,995 % (4N5), 1 g, kunststoffverpackung.

Flibanserin>97.0%(T)(HPLC)25mg

2-(Pyridin-3-yl)aniline, 95.0%, 5g